Edward M. Kaye M.D., Director at CYTOKINETICS INC (CYTK), sold 6,756 shares at $50.00 ($338K) on 2025-09-02, disclosed to the SEC on 2025-09-02.
Scheduled sale ($338k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |